Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2020

Jan 10, 2020

30561_dirs_2020-01-09_673046a0-3f2b-4157-aa88-70a7102bc3fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2020-01-07

Reporting Person: Garber Alan M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-07 Common Stock M 30000 $4.58 Acquired 91329 Direct
2020-01-07 Common Stock M 56956 $5.82 Acquired 148285 Direct
2020-01-07 Common Stock S 86956 $18.01 Disposed 61329 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-01-07 Option (right to buy) $4.58 M 30000 Disposed 2020-05-22 Common Stock (30000.0) Direct
2020-01-07 Option (right to buy) $5.82 M 56956 Disposed 2020-12-05 Common Stock (56956.0) Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2019.

F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F3: The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013.

F4: The option, representing the right to purchase a total of 56,956 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013.